RY
Raj Yogeshbhai Vyas
About Raj Yogeshbhai Vyas
Data last updated:
Raj Yogeshbhai Vyas has 14 years in corporate governance. Holds Director role. Currently with 1 company, including Rasashram Pharma Laboratries Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rasashram Pharma Laboratries Private Limited at ₹2.99 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rasashram Pharma Laboratries Private Limited U24231GJ2001PTC039906 | Director | 07 Jan 2012 | 2001 | ₹2.99 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raj Yogeshbhai Vyas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raj Yogeshbhai Vyas
Raj Yogeshbhai Vyas has 14 years in corporate governance. Holds Director role. Currently with 1 company, including Rasashram Pharma Laboratries Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rasashram Pharma Laboratries Private Limited at ₹2.99 Cr (FY 2025).
Raj Yogeshbhai Vyas is associated with 1 company as Director, including Rasashram Pharma Laboratries Private Limited (₹2.99 Cr).
Raj Yogeshbhai Vyas has expertise in General Business.
Raj Yogeshbhai Vyas has 14 years in corporate governance.
By reported revenue, the largest current company of Raj Yogeshbhai Vyas is Rasashram Pharma Laboratries Private Limited, with revenue of ₹2.99 Cr (FY 2025).
Raj Yogeshbhai Vyas currently holds positions at 1 company: Rasashram Pharma Laboratries Private Limited (₹2.99 Cr).